Key statistics
As of last trade Annexon Inc (ANNX:NSQ) traded at 5.65, -21.31% below its 52-week high of 7.18, set on Jan 23, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 5.71 |
|---|---|
| High | 5.79 |
| Low | 5.46 |
| Bid | 5.65 |
| Offer | 5.68 |
| Previous close | 5.63 |
| Average volume | 1.99m |
|---|---|
| Shares outstanding | 144.55m |
| Free float | 134.33m |
| P/E (TTM) | -- |
| Market cap | 813.79m USD |
| EPS (TTM) | -1.39 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 14:46 GMT.
More ▼
Announcements
- Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
- Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026
- Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome
- Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
- Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million
- Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
- Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
- Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
- Annexon Biosciences to Participate in Upcoming September Investor Conferences
More ▼
